Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia.
about
Hematological disorders and pulmonary hypertension.Deletion of Src family kinase Lyn aggravates endotoxin-induced lung inflammation.Pulmonary arterial hypertension in a patient treated with dasatinib: a case report.Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension.Dasatinib-Induced Pulmonary Arterial Hypertension.Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib.
P2860
Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Reversible Pulmonary Arterial ...... for Chronic Myeloid Leukemia.
@ast
Reversible Pulmonary Arterial ...... for Chronic Myeloid Leukemia.
@en
type
label
Reversible Pulmonary Arterial ...... for Chronic Myeloid Leukemia.
@ast
Reversible Pulmonary Arterial ...... for Chronic Myeloid Leukemia.
@en
prefLabel
Reversible Pulmonary Arterial ...... for Chronic Myeloid Leukemia.
@ast
Reversible Pulmonary Arterial ...... for Chronic Myeloid Leukemia.
@en
P2093
P2860
P356
P1476
Reversible Pulmonary Arterial ...... for Chronic Myeloid Leukemia.
@en
P2093
Dong-Wook Kim
Eun-Jung Jang
Hae Ok Jung
Ho Joong Youn
Hye-Rim Jeon
Jeong-Eun Yi
Ji Hyung Hong
Jin Eok Park
Ju-Hee Bang
Soo Young Choi
P2860
P304
P356
10.4143/CRT.2013.155
P577
2014-11-17T00:00:00Z